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Abstract
Problem—Clostridium sordellii causes endometrial infections but little is known regarding host
defenses against this pathogen.
Method of Study—We tested the hypothesis that the immunoregulatory lipid prostaglandin
(PG) E2 suppresses human macrophage clearance of C. sordellii through receptor-induced
increases in intracellular cAMP. The THP-1 macrophage cell line was used to quantify C. sordellii
phagocytosis.
Results—PGE2 increased cAMP levels, activated protein kinase A (PKA), and inhibited the
class A scavenger receptor-dependent phagocytosis of C. sordellii. Activation of the EP2 and EP4
receptors increased intracellular cAMP and inhibited phagocytosis, with evidence favoring a more
important role for EP4 over EP2. This was supported by EP receptor expression data and the use
of pharmacological receptor antagonists. In addition, the PKA isoform RI appeared to be more
important than RII in mediating the suppression of ingestion of C. sordellii.
Conclusions—The endogenous lipid mediator PGE2 impairs human innate immune responses
against C. sordellii.
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Introduction
Clostridium sordellii is an anaerobic Gram positive bacillus that is found in the environment
and is an uncommon cause of human infection. However, infections caused by toxigenic
strains of C. sordellii can be severe due to the occurrence of a treatment-refractory toxic
shock syndrome1. Women of reproductive age are at increased risk for C. sordellii infections
(including endometritis) that complicate childbirth, abortion, and gynecological procedures2.
Despite aggressive medical and surgical treatment, the mortality of C. sordellii infections
has remained high1. The development of better therapeutic options for C. sordellii infection
is limited by a lack of understanding of fundamental host-microbial interactions involved in
the pathogenesis of infection.
Macrophages are important sentinels of innate immunity in the soft tissues and have been
implicated as critical cellular participants in host defense against tissue-invasive clostridial
infection3-5. It was recently reported that macrophage phagocytosis of vegetative C. sordellii
was mediated by class A scavenger receptors, particularly the macrophage receptor with
collagenous structure (MARCO)6. It was also demonstrated that misoprostol, a
pharmacological analogue of E-series prostaglandins (PG), could impair the phagocytosis of
C. sordellii by rodent macrophages7. This suggested that immune surveillance and clearance
of C. sordellii were susceptible to negative regulation by endogenous PGs, which is
potentially important because the female reproductive tract is replete with PGs during
pregnancy8, 9.
The compound PGE2 is an arachidonic acid-derived lipid mediator generated in abundance
at sites of infection and inflammation as a result of the rapid up-regulation of
cyclooxygenase-2 and microsomal PGE synthase-1 enzymes10. It is also an important
hormonal regulator of reproduction that is generated in the uterus where it is involved in
early and late processes ranging from implantation of the fertilized egg to parturition11.
PGE2 is a highly potent modulator of innate and adaptive immunity that influences cell
behavior through the ligation of its four distinct G protein coupled E-prostanoid (EP)
receptors, numbered EP1-412, 13. Both EP2 and EP4 are potent immunoregulatory receptors
that share the capacity to increase intracellular concentrations of cyclic adenosine
monophosphate (cAMP) within seconds to minutes of PGE2 binding13, 14. PGE2-dependent
increases in cAMP have been shown to impair the phagocytic ability of different
macrophage types against a range of pathogens15-18, and it can be suggested that such
effects might have evolved to limit the extent of host inflammatory responses or trigger the
resolution of inflammation. However, in clinical situations such as pregnancy and the
puerperium, where local and systemic PGE2 levels are elevated for physiological
reasons19-21, the immunosuppressive effects of PGE2 might be maladaptive, particularly
when an opportunistic pathogen such as C. sordellii gains access to the normally uninfected
uterus (or surrounding soft tissue).
The purpose of this study was to address the question of whether PGE2 and cAMP-signaling
cascades could regulate the phagocytosis of C. sordellii by human macrophages and to
determine the involvement and relative importance of EP2 and EP4 receptors in such
regulation. A better understanding of endogenous regulators of innate immunity will
enhance efforts to develop better preventive and therapeutic options against reproductive
tract infections.
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Materials and Methods
THP-1 cells
Phorbol-12-myristate-13-acetate (PMA)-differentiated THP-1 cells (a human macrophage-
like cell line) were used in this study. These cells were obtained from the American Type
Culture Collection (ATCC, TIB-202; Manassas, VA) and cultured in RPMI 1640
(Invitrogen, Carlsbad, CA) supplemented with 1% antibiotic-antimycotic (Invitrogen) and
10% charcoal/dextran treated fetal bovine serum (FBS; HyClone, Waltham, MA), referred
to as RPMI +/+. Cells were passaged every 2-4 days and were used through the 10th
passage, at which time a new culture was started. THP-1 cells were matured into
macrophages by culturing with 100 nM PMA (Sigma-Aldrich, St. Louis, MO) in RPMI +/+
for 24 hr at 37°C with 5% CO2. Cells were detached from the flask with non-enzymatic cell
dissociation solution (Sigma-Aldrich) and gentle scraping. PMA-activated THP-1 cells were
used for all experiments presented here, unless otherwise noted.
Bacteria
The lethal toxin-expressing C. sordellii strain 9714 was obtained from the ATCC and grown
anaerobically for 48 hr at 37°C in reinforced clostridial medium (RCM; BD Biosciences,
San Jose, CA). Bacterial concentrations were estimated from the optical density (OD) of
bacterial cultures at 600 nm (OD600) and a standard curve of colony forming units (CFU) vs.
OD600. Estimated bacterial concentrations were confirmed by serial 10-fold dilutions on
solid RCM containing 1.5% agar, incubated overnight anaerobically. For phagocytosis
experiments (below), heat-killed, vegetative C. sordellii were prepared by incubating at
65°C for 2 hr. Spore contamination was estimated by Schaeffer and Fulton Spore Stain
(Sigma-Aldrich) to be < 10%. Heat-killed C. sordellii were then surfaced-labeled with either
FITC, per our previously published protocol7, or [C15H16N3]+[Zn8S(SC6H5)15·H2O]− (abbr.
JX90a) as previously published22. Although qualitative results using either fluorophore were
similar, the fluorescent labeling was brighter with JX90a. Therefore it was used for many of
the experiments in preference to FITC. Briefly, heat-killed C. sordellii were labeled
overnight in NaHCO3 buffer (pH 9.2) with 100 μM of the bacterial dye JX90a. Bacteria
were washed with PBS by centrifugation and stored at −80°C in single-use aliquots until
each phagocytosis assay was performed. Herein, we refer to fluorescently labeled C.
sordellii (using either FITC or JX90a) as FLUORC. sordellii.
Phagocytosis Assays
PMA-activated THP-1 cells were treated in RPMI +/− (lacking FBS) with compounds of
interest and incubated for 15 or 30 min at 37°C as indicated, on 384-well tissue-culture
treated plates. All conditions were performed in replicates of eight. Cells were inoculated
with FITC- or JX90a-labeled C. sordellii (FLUORC. sordellii) at a multiple of infection
(MOI) of 300 bacteria:1 cell and incubated for 3 hr at 37°C. Phagocytosis was quantified
according to our published method of measuring intracellular fluorescence as a surrogate
marker of bacterial ingestion by macrophages15. The fluorescence of intracellular FLUORC.
sordellii was determined using a microplate fluorometer (485ex/535em FITC; 470ex/500em
JX90a, SPECTRAMax GEMINI EM; Molecular Devices, Sunnyvale, CA) according to our
previously published method15. Briefly, fluorescence was expressed in relative fluorescence
units (RFU), which were converted into a phagocytic index (PI). The PI represents the
fluorescence of intracellular (phagocytosed) bacteria (RFUi) and was calculated from the
total fluorescence of the well (RFUtotal) by subtracting the fluorescence of extracellular
bacteria (RFUex). The RFUex was determined by treating some cells with the phagocytosis
inhibitor, cytochalasin D (20 μg/ml; EMD Chemicals, Billerica, MA), for 30 min prior to
exposure to FLUORC. sordellii23. The mean RFUex determined from cytochalasin-treated
wells was then subtracted from the RFUtotal. Therefore, the PI = RFUi = RFUtotal - RFUex15.
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Treatments used in our phagocytosis assay included the phagocytosis inhibitor, cytochalasin
D (30 min, 20μg/mL); prostaglandin E2 (PGE2; 15 min, 0.1, 1μM; Cayman Chemicals, Ann
Arbor, MI); cAMP analogs adenosine 3′, 5′-cyclic monophosphate 8-bromo-sodium salt (8-
Bromo-cAMP; dual activator of protein kinase A (PKA) and exchange protein directly
activated by cAMP (EPAC-1)), adenosine 3′,5′-cyclic monophosphate N6–benzoyl sodium
salt (6-Bnz-cAMP; PKA-specific), and adenosine 3′-5′-cyclic monophosphate 8-(4-
Chlorophenylthio)-2′-O-methyl sodium salt (8-pCPT-cAMP; EPAC-1-specific) (each 30
min, 0.1, 0.2, 1, 2mM; EMD Chemicals); the EP2 agonist butaprost free acid (BFA; 15 min,
1, 10μM; Cayman Chemicals); the EP4 agonist L-902,688 (15 min, 1, 10μM; Cayman
Chemicals); the EP2 antagonist AH6809 (15 min, 1μM; Cayman Chemicals); the EP4
antagonist ONO-AE1-208 (15 min, 1μM; gift from the Ono Pharmaceutical company in
Osaka, Japan); the nonselective class A scavenger receptor antagonists fucoidan (30 min,
1mg/mL; Sigma-Aldrich) and dextran sulfate (30 min, 0.2mg/mL; MP Biomedicals, Solon,
OH); and the negative control agent chondroitin sulfate (30min, 0.2mg/mL; Sigma-Aldrich);
the PKA RI agonist 2-Cl-8-MA-cAMP and the PKA RII agonist 6-MBC-cAMP (both
30min, 500μM; Axxora, Farmingdale, NY).
Measurement of intracellular cAMP
PMA-activated THP-1 cells were cultured in 6-well tissue-culture treated plates at a
concentration of 3 × 106 cells/well in RPMI +/−. Cells were incubated with PGE2, BFA,
L-902,688, AH6809, or ONO-AE1-208 (1 or 10μM) for 15 min. Culture supernatants were
removed and cells were lysed by incubation with 0.1M HCl for 10 min at room temperature
followed by gentle scraping. Lysates were harvested by centrifugation and stored at −80°C.
Intracellular cAMP levels were measured by EIA according to the manufacturer (Enzo/
Assay Designs, Ann Arbor, MI), and all samples were assayed in triplicate.
Measurement of PKA activation
The activation of PKA was assessed by quantitative immunoblot of the PKA
phosphorylation target vasodilator-stimulated phosphoprotein (VASP)24, 25. THP-1 cells
were PMA-activated for 48 hr followed by an overnight rest period in RPMI +/+. PMA-
activated THP-1 cells were then treated for 15 min with 1μM PGE2 in 100 mm2 tissue-
culture treated dishes before lysis in Lysis Buffer #6 (R&D Systems, Minneapolis, MN).
Protein samples (40μg) were resolved on 10% Tris-HCl polyacrylamide gels and transferred
to a nitrocellulose membrane. Membranes were probed with phospho-(Ser157) VASP rabbit
antibody (Cell Signaling Technology, Danvers, MA), followed by HRP-conjugated anti-
rabbit secondary antibody and Pierce ECL detection reagents (Thermo Scientific, Rockford,
IL). Quantification of the phospho-target was normalized to the housekeeping protein α-
tubulin.
Immunoblot analysis of EP2 and EP4 receptors
Non-PMA treated THP-1 cells in suspension were centrifuged and lysed in Lysis Buffer #6.
Protein samples (40μg) were resolved on 10% Tris-HCl polyacrylamide gels and transferred
to a nitrocellulose membrane. Membranes were probed with the EP2 and EP4 receptor
polyclonal antibodies (Cayman Chemicals), followed by HRP-conjugated anti-rabbit
secondary antibody and Pierce ECL detection reagents. Quantification of each receptor was
normalized to the housekeeping protein α-tubulin.
Quantitative real-time PCR analysis
PMA-activated THP-1 cells were stored in Trizol Reagent (Invitrogen) at −80°C until RNA
was extracted and cDNA was generated per our previously published protocol6. Human
primers and probes were designed using the Roche Universal Probe Library Assay Design
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Center. Primers were generated by Integrated DNA Technology and all probes were from
Roche (Basel, Switzerland). Primers used are as follows: human EP2 forward 5′-GGA GGA
GAC GGA CCA CCT-3′, EP2 reverse 5′- GTT TCA TTC ATA TAT GCA AAA ATC
GT-3′ (Universal Probe Library #2); human EP4 forward 5′-CTC CCT GGT GGT GCT
CAT-3′, EP4 reverse 5′-GGC TGA TAT AAC TGG TTG ACG A-3′ (Universal Probe
Library # 58). The Universal Probe Library Gene Assay (Roche) for human GAPDH was
also used (Universal Probe Library # 60). Samples were run on the Light Cycler 480
(Roche) with the following conditions: 95°C, 10 min (pre-incubation); 95°C 10 sec; 60°C,
30 sec; 72°C, 1 sec (amplification, 45 cycles); 95°C, 10 sec; 50°C, 30 sec; 70°C, 5 min
(melting curve); 40°C, 30 sec (cooling). Analysis was performed using the Roche software
and expression of each gene was referenced to the expression of the housekeeping gene
GAPDH. Results were calculated using the 2−ΔΔCT method26.
Statistical analyses
Statistical analyses were carried out using GraphPad Prism 5.0 software for Windows
(GraphPad Software, San Diego California USA). Unless otherwise stated, experimental
data are presented as a percentage of the untreated control group (set at 100%). Error bars
represent the standard error of the mean (SEM). All analyses were conducted on raw data
prior to normalizing to the untreated control. Where appropriate, mean values were
compared using a paired Student t-test or a repeated measured analysis of variance
(ANOVA). A Dunnett post test was conducted for comparisons with the control value, or a
Tukey test was performed for multiple comparisons. Differences were considered significant
if P ≤ 0.05. Experiments were performed on at least three separate occasions.
Results
Prostaglandin E2 inhibits the class A scavenger receptor dependent phagocytosis of
unopsonized C. sordellii by THP-1 cells
The PGE1 analogue misoprostol, which binds to the same four EP receptors as does PGE227,
was previously found to inhibit the phagocytosis of vegetative C. sordellii by rodent
macrophages7. The capacity for authentic PGE2 to regulate human phagocyte-clostridial
interactions has not been examined. Human THP-1 macrophage-like cells were used to
model the regulation of phagocytosis of unopsonized, vegetative C. sordellii. Although C.
sordellii phagocytosis has been shown to be mediated by class A scavenger receptors
(CASRs) in rodent macrophages and human decidual macrophages6, the dependence on
CASRs for internalization of C. sordellii by THP-1 cells was unknown. Therefore, initial
experiments were performed with the CASR-blocking compound fucoidan (1 mg/mL),
which almost completely prevented the phagocytosis of FLOURC. sordellii by THP-1 cells (P
< 0.001), confirming the importance of CASRs in this process (Fig. 1A). Additionally, when
cells were treated with the standard, nonselective CASR blocking agent dextran sulfate at
0.2 mg/mL, there was an inhibition of 81.6 ± 3.5% of phagocytic activity (P < 0.001), while
the negative control agent chondroitin sulfate had a minimal effect at the same dose (Fig.
1A). Exposure of THP-1 cells to exogenously-added PGE2 (0.1 or 1 μM) dose-dependently
inhibited the phagocytosis of unopsonized FLUORC. sordellii (Fig. 1B), with an inhibition of
35 ±12.7% (P < 0.05) and 54.7 ± 14.5% (P < 0.01), respectively.
Activation of EP2 and EP4 receptors increases cAMP in THP-1 cells and this effect is
blocked with an EP4 antagonist
The Gαs coupled EP2 and EP4 receptors are important immunoregulatory receptors on
macrophages15, 28-30 and THP-1 cells have been reported to express both EP2 and EP4
receptors31. We therefore verified that PGE2 could increase cAMP in THP-1 cells, finding a
20 ± 3.7-fold increase (P < 0.0001) with 1 μM PGE2 (Fig. 1C). That both EP2 and EP4
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receptors were active in these cells was supported by an increase in cAMP observed when
cells were incubated for 15 min with the selective EP2 or EP4 agonists BFA or L-902,688,
respectively (Fig. 2A). The activation of the EP2 receptor evoked 1.8-fold and 3.3-fold
increases in cAMP with BFA (1 and 10 μM, respectively), while EP4 stimulation with
L-902,688 induced 7.1-fold (P < 0.001) and 5.7-fold (P < 0.05) increases in cAMP (1, 10
μM, respectively). To further explore EP2 and EP4 activation on THP-1 cell phagocytosis,
cells were pretreated with L-902,688 or BFA for 15 min. It was found that L-902,688 (EP4
agonist) exposure suppressed the capacity of THP-1 cells to ingest unopsonized FLUORC.
sordellii, while BFA was effective but not quite as potent (Fig. 2B). EP2 and EP4
antagonists were used to define the extent to which these receptors mediate the actions of
PGE2 on THP-1 cells. As indicated in Fig. 2C, cAMP increases provoked by PGE2 were
blocked by the EP4 antagonist ONO-AE1-208 but not by the EP2/DP1 antagonist AH6809
(1 μM each).
EP4 receptors are expressed in greater abundance than EP2 receptors by THP-1 cells
To confirm EP2 and EP4 receptor expression by THP-1 cells, cells were lysed and subjected
to immunoblot analysis for the detection of these receptors. A band at the expected
molecular weight of ∼52 kDa was observed for the EP2 receptor but as evidenced in Fig.
2D several larger bands were also detected, which are of uncertain significance. A single
band at the expected 65 kDa was detected for EP4 (Fig. 2E). Because the EP2 immunoblot
result was inconclusive, experiments were conducted to determine mRNA expression levels
of EP2 and EP4 using quantitative real-time PCR. RNA was isolated, cDNA was reverse
transcribed, and real-time PCR was performed for EP2 and EP4. We found significantly
higher expression of EP4 compared with EP2 by THP-1 cells (P < 0.01) (Fig. 2F).
PKA activation inhibits C. sordellii phagocytosis
Once cAMP is generated in a macrophage it can activate downstream signaling cascades by
binding to effector proteins such as the Ser/Thr phosphorylating enzyme called protein
kinase A (PKA) or the guanine-nucleotide exchange protein directly activated by cAMP
(Epac-1)32. Experiments were conducted to determine whether cAMP itself could regulate
phagocytosis of C. sordellii and, if so, through which effector proteins. Thus, cells were
pretreated with the dual (non-selective) PKA/Epac-1 activator and cAMP analogue 8-Br-
cAMP, which significantly reduced phagocytosis by 38.2 ± 7.4% (P < 0.01) at a
concentration of 1 mM (data not shown). To determine whether the activation of either PKA
or Epac-1 (or both) mediated the actions of cAMP on this process, cells were pretreated with
the PKA or Epac-1-selective agonist's 6-Bnz-cAMP or 8-pCPT-2′-O-Me-cAMP,
respectively. As illustrated (Fig. 3A&B), only PKA activation resulted in suppression of
phagocytosis.
PKA is activated by PGE2 as seen by phosphorylation of VASP
The data above demonstrate that PGE2 both inhibited C. sordellii phagocytosis and
enhanced cAMP in THP-1 macrophages, while the cAMP-dependent activation of PKA was
sufficient to suppress phagocytosis. To determine whether PGE2 treatment can directly
activate PKA, we measured the phosphorylation of a canonical protein target of PKA in
response to treatment of cells with PGE2. VASP is a member of the Ena-VASP protein
family that is phosphorylated by PKA and is a robust surrogate for that activity24, 25. THP-1
cells were exposed for 15 min with 1 μM PGE2 and immunoblot analysis was performed for
phospho-VASP (Fig. 3C). As noted, PGE2 treatment resulted in an 11.2-fold (P < 0.05)
increase in phosphorylation of VASP when compared to untreated control.
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Activation of PKA isozyme type I, not type II, counter-regulates C. sordellii phagocytosis
The cAMP-dependent PKA exists in two major isoforms, defined by their regulatory
(cAMP-binding) subunits: types RI and RII33. Emerging data suggest that cellular functions
in macrophages are governed by distinct isoforms34. We examined the capacity for type RI
and RII agonists (2-Cl-8-MA-cAMP and 6-MBC-cAMP, respectively) to regulate
phagocytosis of C. sordellii and found that activation of PKA type RI resulted in an
inhibition of 33.8 ± 9.4% (P < 0.01), while PKA type RII only inhibited phagocytosis by 7.2
± 4.8% (Fig. 3D).
Discussion
Globally, more than 500,000 women die from complications of pregnancy and childbirth
each year35, and nearly 1 in 8 maternal deaths is due to unsafe abortion36, 37. Sepsis is a
principal cause of maternal death after childbirth38 or abortion37. Pregnancy itself is
associated with major shifts in immune surveillance39 as the maternal immune system must
be “detuned” to accommodate the immunologically-distinct fetus40. Despite this, a mother's
immune system must be able to detect and respond to potentially pathogenic organisms.
However, some pathogens have evolved mechanisms to evade host defense, apparently
taking advantage of the immunological shifts associated with pregnancy. For example,
certain Gram positive bacteria are adept at causing pregnancy-related infections, including
Listeria monocytogenes, Streptococcus pneumoniae, Group A Streptococcus, Group B
Streptococcus, and the clostridia41-43. Clostridium sordellii infections have increasingly
been observed over the past decade in healthy women of reproductive age following
childbirth or abortion2. In addition to C. sordellii, there is an unexplained association
between C. difficile colitis and both pre- and postpartum women44, 45. The basis for the
enhanced susceptibility of postpartum women to infection remains to be solved.
Major gaps in our understanding of immune surveillance and host defense against clostridial
infections are apparent, in part because the field is understudied. Recent work in this area
has focused on C. difficile and C. perfringens but has not explored reproductive tract
immune defenses3, 5, 46, 47. Macrophages are important in defending the host against
invasive clostridial infections such as C. perfringens3, 48 and are adept at recognizing
clostridia as either spores or vegetative bacteria and targeting them for immune
clearance5, 6, 49. Better understanding the host factors that regulate macrophage-clostridial
interactions may reveal how such pathogens evade host defenses to establish infection.
Our experiments newly establish that macrophage phagocytosis of C. sordellii is subject to
immunoregulation by the immunomodulatory lipid mediator PGE2. In the human THP-1
macrophage cell line this effect appeared to be primarily mediated by the EP4 receptor with
additional involvement of the EP2 receptor. The evidence that EP4 might be more important
than EP2 was based on pharmacological stimulation and/or antagonism of these receptors, as
well as mRNA and Western immunoblot data. The latter immunoblot experiments identified
a clear band of the appropriate size for the EP4 receptor but the EP2 antibody data were less
conclusive. Further studies using receptor silencing or genetic knockout animals could
provide additional evidence for the relative importance of these receptor isoforms in
mediating PGE2's actions. Activation of adenylate cyclase by these receptors caused an
acute burst of intracellular cAMP that activated the canonical target PKA. Further studies
implicated the RI isoform of PKA as a regulatory signaling component governing PGE2/
cAMP modulation of C. sordellii phagocytosis (summarized in Fig. 4). A key unanswered
question requiring future study is how PKA activation reduces CASR-dependent
phagocytosis. It has been reported that PGE2 suppresses macrophage expression of the class
B scavenger receptor CD3650, 51, suggesting that CASR expression might be similarly
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reduced. However, the effects of PGE2 on phagocytosis are rapid (within 15 minutes of
exposure), which would support actions unrelated to new protein expression.
Our findings may have relevance to the pathogenesis of puerperal infections in addition to
those caused by clostridia. Throughout gestation, PGE2 dampens maternal immune
responses against fetal tissues52-55. At term, systemic and local PGE2 levels increase
dramatically19, 21 to induce cervical softening and uterine smooth muscle contraction that
aids in delivery9. It is this spike in PGE2 production at term that may pose a risk for
puerperal sepsis. Relevant to this paradigm, a stable PGE2 analogue delivered into the
maternal cervix postpartum in cows increased the incidence of puerperal endometritis56
while a mouse study reported that PGE2 facilitated the establishment of chlamydial uterine
infections57. Thus, high PGE2 levels in the female reproductive tract at parturition might
increase susceptibility to puerperal infection.
These investigations were limited by their in vitro design. Studies in women or animal
models will be important to determine the extent to which PGE2 regulates clostridial
pathogenesis in vivo. Preliminary experiments in our laboratory revealed increased mortality
in mice exposed to PGE2 in utero during C. sordellii spore infection (data not shown) and
this is a future direction for our lab. What is more, our work was largely conducted using a
cell line. While the THP-1 cell is a standard human macrophage-like cell line58, these cells
may not be an accurate model of primary reproductive tract macrophages. They were
originally isolated from a child with leukemia [Tsuchiya, 1980 #3232]. We have previously
found that THP-1 cells behave similarly to primary placental macrophages in their capacity
to phagocytose S. pyogenes and to be regulated by lipid mediators59. Thus, understanding
the mechanisms whereby PGE2 regulates THP-1-C. sordellii interactions may be relevant to
reproductive tract innate immunity.
Another limitation of our work was the use of heat-killed bacteria. While advantageous for
studying bacteria-receptor interactions without the confounding effects of bacterial products
on host cell function, such effects might be relevant in vivo. Clostridium sordellii produces
cytotoxins that could regulate macrophage function. Future studies will be needed to
determine the extent to which C. sordellii toxins impact macrophage antibacterial defense
functions. Lastly, we conducted these studies using vegetative forms of C. sordellii. As a
spore-forming anaerobe, it may be equally relevant to define how macrophages recognize
and attempt to clear spores of C. sordellii from the infected host. Future studies will be
needed to address this issue.
In summary, these data reveal that the endogenous lipid molecule PGE2 can limit the
capacity for THP-1 cells to phagocytose unopsonized C. sordellii and this occurs primarily
via EP4-mediated activation of PKA signaling cascades. New preventive and therapeutic
strategies against this and other reproductive tract bacterial infections may be identified by
studying eicosanoid immunoregulation of immune defenses in the uterus.
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Figure 1. Prostaglandin E2 inhibits class A scavenger receptor-dependent phagocytosis of
unopsonized C. sordellii by THP-1 cells
Cells were treated with the class A scavenger receptor antagonists (A) fucoidan, dextran
sulfate, or the structurally similar negative control chondroitin sulfate for 30 min (n=3-4), or
(B) PGE2 (n=6) for 15 min prior to challenge with FLUORC. sordellii as described in
Materials and Methods. Phagocytosis was quantified by fluorometry. Data are mean ± SEM.
**, p<0.01; ***, p<0.001 by ANOVA. (C) Cells were treated with PGE2 for 15 min before
lysis with 0.1M HCl and cAMP measurement by EIA (n=12). Data are mean ± SEM. ****,
p<0.0001 by Student paired t-test compared to untreated controls.
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Figure 2. EP2 and EP4 receptors mediate PGE2-induced intracellular cAMP increase and
phagocytosis inhibition in THP-1 cells
Cells were treated for 15 min with (A) the EP2 agonist butaprost free acid (BFA) or the EP4
agonist L-902,688 (n=3-5). Cells were lysed and cAMP was measured by EIA. (B) Cells
were treated for 15 min with BFA or L-902,688 followed by a challenge with FLUORC.
sordellii (n=4). Phagocytosis was quantified by fluorometry. (C) Cells were pre-treated for
15 min with either the EP2 antagonist (AH6809) or the EP4 antagonist (ONO-AE1-208),
then PGE2 was administered for an additional 15 min (n=3), cells were lysed and cAMP was
measured by EIA. Data in (A-C) are represented as mean ± SEM. *, p<0.05; **, p<0.01;
****, p<0.0001 by ANOVA compared to the untreated control. Cells were lysed and
immunoblot analysis was performed for (D) EP2 and (E) EP4 receptors (n=5 each;
representative immunoblots). (F) qRT-PCR was performed for EP2 and EP4 on THP-1 cells
(n=3). Data are represented as mean ± SEM of fold regulation. **, p<0.01 by unpaired
Student t-test comparing EP2 to EP4.
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Figure 3. The PGE2-mediated inhibition of phagocytosis seen in THP-1 cells is PKA dependent
and not EPAC-1 dependent
Cells were treated for 30 min with (A) 6-Bnz-cAMP, a PKA-dependent cAMP analogue
(n=3) or (B) 8-pCPT-cAMP, an EPAC-1 dependent cAMP analogue (n=3), or (D) the PKA
RI agonist 2-Cl-8-MA-cAMP or the PKA RII agonist 6-MBC-cAMP for 30 min (n=5),
followed by a challenge with FLUORC. sordellii. Phagocytosis was quantified by
fluorometry. Data in A, B, and D panels are represented as mean ± SEM. **, p<0.01 by a 1
way ANOVA with a Dunnett's multiple comparison test compared to untreated control. (C)
Cells were treated with 1 μM PGE2 for 15 min, lysed, and immunoblot analysis was
performed for phospho-VASP, a marker of PKA activation (n=5). Data are shown as mean ±
SEM. *, p<0.05 by a paired Wilcoxon matched-pairs signed rank test.
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Figure 4. A conceptual model of PGE2 inhibition of vegetative C. sordellii phagocytosis by THP-1
cells
Vegetative C. sordellii bacteria are phagocytosed via class A scavenger receptors (CASR).
PGE2 stimulated intracellular cAMP synthesis by adenylate cyclase (AC) following ligation
of the Gαs-coupled EP2 and EP4 receptors. The cAMP burst in turn activated the type I
isoform of protein kinase A (PKA-RI), which is involved in suppressing the internalization
of C. sordellii. Pharmacological tools used in these experiments include the EP2 agonist
butaprost free acid (BFA), the EP2 agonist L-902,688, the EP2 antagonist AH-6809, the EP4
antagonists ONO AE1-208, and the PKA RI agonist 2-Cl-8-MA-cAMP.
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